BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6341348)

  • 1. The isolation of thymidine-requiring Haemophilus influenzae from the sputum of chronic bronchitic patients receiving trimethoprim.
    Platt DJ; Guthrie AJ; Langan CE
    J Antimicrob Chemother; 1983 Mar; 11(3):281-6. PubMed ID: 6341348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the Thymidylate Synthase
    Rodríguez-Arce I; Martí S; Euba B; Fernández-Calvet A; Moleres J; López-López N; Barberán M; Ramos-Vivas J; Tubau F; Losa C; Ardanuy C; Leiva J; Yuste JE; Garmendia J
    Front Cell Infect Microbiol; 2017; 7():266. PubMed ID: 28676846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility patterns of nonserotypable Haemophilus influenzae from patients with chronic bronchitis.
    Butt HL; Cripps AW; Clancy RL
    Pathology; 1997 Feb; 29(1):72-5. PubMed ID: 9094183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro resistance of haemophilus influenzae to co-trimoxazole and trimethoprim.
    Cornere BM; Menzies R
    N Z Med J; 1975 Mar; 81(536):292-4. PubMed ID: 1079587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Haemophilus influenzae isolates from blood and cerebrospinal fluid to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole.
    McGowan JE; Terry PM; Nahmias AJ
    Antimicrob Agents Chemother; 1976 Jan; 9(1):137-9. PubMed ID: 1083198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sulfamethoxazole-trimethoprim and ampicillin in the treatment of bronchitis].
    Hoiby N
    Ugeskr Laeger; 1973 May; 135(22):1082. PubMed ID: 4148390
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro susceptibility of Haemophilus influenzae to trimethoprim-sulfamethoxazole.
    Kirven LA; Thornsberry C
    Antimicrob Agents Chemother; 1974 Dec; 6(6):869-70. PubMed ID: 4548834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of Haemophilus influenzae to trimethoprim.
    May JR; Davies J
    Br Med J; 1972 Aug; 3(5823):376-7. PubMed ID: 4538444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim-sulfamethoxazole in the treatment and prevention of purulent exacerbations of chronic bronchitis.
    Pines A
    J Infect Dis; 1973 Nov; 128():Suppl:706-9 p. PubMed ID: 4148417
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemophilus influenzae biotypes and chronic bronchitis.
    Kilbourn JP; Haas H; Morris JF; Samson S
    Am Rev Respir Dis; 1983 Dec; 128(6):1093-4. PubMed ID: 6606372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative inhibition of Haemophilus influenzae by trimethoprim/sulfamethoxazole.
    Pelton SI; Shurin PA; Klein JO; Finland M
    Antimicrob Agents Chemother; 1977 Dec; 12(6):649-54. PubMed ID: 303886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimum bactericidal concentration of sulfamethoxazole-trimethoprim for Haemophilus influenzae: correlation with prophylaxis.
    Kirven LA; Thornsberry C
    Antimicrob Agents Chemother; 1978 Nov; 14(5):731-6. PubMed ID: 310281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of clinical isolates of Haemophilus influenzae in United Kingdom 1986.
    Powell M; Koutsia-Carouzou C; Voutsinas D; Seymour A; Williams JD
    Br Med J (Clin Res Ed); 1987 Jul; 295(6591):176-9. PubMed ID: 3115364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The taxonomy and antimicrobial susceptibility of Haemophilus species in clinical specimens.
    Golberg R; Washington JA
    Am J Clin Pathol; 1978 Dec; 70(6):899-904. PubMed ID: 364976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a selective medium for the isolation and differentiation of Haemophilus influenzae and Haemophilus parainfluenzae from the respiratory tract of chronic bronchitics.
    Taylor DC; Cripps AW; Clancy RL; Murree-Allen K; Hensley MJ; Saunders NA; Sutherland DC
    Pathology; 1990 Jul; 22(3):162-4. PubMed ID: 2243729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A method for testing susceptibility of Haemophilus influenzae to co-trimoxazole (author's transl)].
    Machka K; Balg H; Smith M; Braveny I
    Immun Infekt; 1978 Dec; 6(6):249-52. PubMed ID: 103805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriology of the sputum in exacerbation and remission of chronic bronchitis.
    Scott KW
    Br J Dis Chest; 1973 Jan; 67(1):43-8. PubMed ID: 4540042
    [No Abstract]   [Full Text] [Related]  

  • 18. Human lactoferrin receptor activity in non-encapsulated Haemophilus influenzae.
    Vogel L; Geluk F; Jansen H; Dankert J; van Alphen L
    FEMS Microbiol Lett; 1997 Nov; 156(1):165-70. PubMed ID: 9368377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility, growth kinetic and pathogenicity of thymidine-requiring Streptococcus species.
    Fu KP; Kimble EF; Coldreck RJ; Konopka EA
    Chemotherapy; 1984; 30(6):373-8. PubMed ID: 6335073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twice daily dosage of bacampicillin in chronic bronchitis. A double-blind study.
    Davies BI; Maesen FP; Brombacher PJ; Sjövall J
    Scand J Respir Dis; 1978 Oct; 59(5):249-56. PubMed ID: 32615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.